Lymphoepithelioma-like hepatocellular carcinoma

Jun-Ke Wang,Yanwen Jin,Hai Hu,Parbatraj Regmi,Wen-Jie Ma,Qin Yang,Fei Liu,Congdun Ran,Fei Su,E. Zheng,Fuyu Li
DOI: https://doi.org/10.1097/MD.0000000000009416
IF: 1.6
2017-12-01
Medicine
Abstract:Rational: Lymphoepithelioma-like hepatocellular carcinoma (LEL-HCC) is a rare variant of hepatocellular carcinoma (HCC). To date, few cases have been reported in the literature, and almost no report in analyzing the different features of LEL-HCC. Patient concerns: We describe a 37-year-old female patient with a 32 × 30 mm mass in the right liver. Interventions: Complete surgical resection of the lesion was performed. Diagnoses: Histopathological examination of the resected tumor revealed undifferentiated HCC cells with significant lymphocytes infiltration. Immunohistochemically, the tumor cells were positive for AFP (alpha fetoprotein), hepatocyte, CK8, and glypican-3. The patient was diagnosed with LEL-HCC. Outcomes: The patient had a favorable clinical outcome, and was free from tumor recurrence after a 52-months follow-up. Lessons: Our case was the youngest patient of all the reported cases, and the third case who was infected with both hepatitis B virus (HBV) and hepatitis C virus (HCV). LEL-HCC is a rare variant of HCC, with a relatively favorable prognosis. Further research recruiting more patients is required to determine the accurate causes and mechanism of LEL-HCC.
What problem does this paper attempt to address?